Skip to main content
Caplight Logo









Histocell

Histocell

Private
DerioHealthcare & Life Scienceshttps://histocell.com/

Last Round

Corporate Funding

Dec 12, 2022

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Histocell is a biotechnology company that develops and manufactures cell therapy products, biological medicinal products, and innovative medical devices for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

CDMOcell therapyregenerative medicineadvanced therapy medicinal productsATMPGMP manufacturingcontract manufacturingbiotech manufacturingtissue engineeringmedical devicesbiomaterialsprocess developmentbiotech outsourcingwound caredermocosmetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Histocell Comparables

Compare Histocell with similar companies based on industry and business-model similarity.

Histocell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stemmatters, Biotecnologia e Medicina Regenerativa S.A.
91%
Cell-Easy
86%
eXmoor Pharma
84%

Histocell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingDec 12, 2022
Corporate FundingNov 24, 2022
VC RoundSep 14, 2018
VC RoundSep 30, 2016
VC RoundApr 1, 2015

Key People

Founding team and executive leadership

Naiara de Paz

COO - Chief Operating Officer at Histocell, Dermocosmetics brand Manager

Executive Team

Histocell Investors

Notable investors and investment history

Histocell investors
InvestorRounds
Seed Capital BizkaiaVC Round
Gestión de Capital Riesgo del País Vasco - Grupo SPRIVC Round
OrzaVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 202% MoM, reaching 1.7K.

  • Nov 11, 2025

    Monthly visitors grew 39% MoM, reaching 755.

Histocell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Histocell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Histocell's valuation, stock price, and market status.

Firmographic Details

HeadquartersDerio
Employee Range41
Year Founded2008
Last FundingDec 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?